Patents Assigned to DYBLY AG
  • Preparation of condensed triazepine derivatives and their use as BET inhibitors
    Patent number: 10906917
    Abstract: The invention relates to compounds of the formula: and pharmaceutically acceptable salts thereof. These compounds are useful in the treatment of inflammatory diseases, fibtrotic diseases and neoplastic diseases.
    Type: Grant
    Filed: March 6, 2020
    Date of Patent: February 2, 2021
    Assignee: DYBLY AG
    Inventors: Herman Kempen, Adel Far